ArticleFrontiers in endocrinology2025
Threshold effects of bone mineral density on mortality risk: a comprehensive analysis of BMI-mediated pathways in older population.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Burden and temporal trends attributable to low bone mineral density in Mexico, 1990-2023: a global burden of disease analysis.Archives of osteoporosis · 2026Article
- Radiographic Assessment of Normal Periapical Bone Density: A Descriptive Analysis Based on Digital Imaging.International journal of dentistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The precise relationship between bone mineral density (BMD) and all-cause mortality in older adults remains incompletely understood. This study aimed to investigate the association between BMD and all-cause mortality and to explore the mediating role of body mass index (BMI) in adults aged ≥60 years. Methods: A cohort study was conducted using data from the National Health and Nutrition Examination Survey (2007-2010, 2013-2014, and 2017-2018), including 6,289 participants aged ≥60 years. The application of Cox proportional hazards models enabled the evaluation of the association between BMD and all-cause mortality, while causal mediation analysis was performed to assess the mediating effect of BMI. Results: This study revealed that among the 6,289 participants, 1,422 (22.61%) deaths occurred during the follow-up period. The findings showed that there was a J-shaped association between BMD and all-cause mortality, with an increased mortality risk observed as BMD decreased. Higher BMD was associated with lower mortality risk, with evidence suggesting both direct and BMI-related pathways. The total effect was strongest for total femur BMD (-0.056, P<0.0001), followed by intertrochanter (-0.061, P<0.0001), trochanter (-0.043, P<0.0001), and femoral neck (-0.025, P=0.002). BMI appeared to partially mediate the protective associations, with varying proportions observed across sites: femoral neck (24.18%), trochanter (12.83%), total femur (11.17%), and intertrochanter (9.20%). The pathway analysis revealed that BMI was found to partially mediate the association between BMD and all-cause mortality. These associations remained robust after adjusting for demographic, socioeconomic, and clinical confounding factors. Conclusions: This study identified site-specific threshold effects of BMD on mortality and quantified the mediating role of BMI. The findings suggest that maintaining an optimal BMI may be associated with reduced mortality risk for individuals with low BMD. Integrated interventions targeting both bone density and body mass management could be more effective in reducing mortality risk among older adults with low BMD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.